Echolight
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Echolight - overview
Established
2010
Location
Lecce, -, Italy
Primary Industry
Medical Devices & Equipment
About
Echolight develops innovative medical imaging solutions focused on bone health, utilizing proprietary technology to provide rapid, radiation-free assessments for bone density and quality. Founded in 2010 in Lecce, Italy, Echolight specializes in advanced medical imaging technology for bone health assessment. The company was co-founded by Matteo Pernisa and is currently led by CEO Sergio Casciaro. It raised EUR 4 million in Series A funding in June 2016, which has been instrumental in supporting its growth initiatives.
The company has a total of 1 investment deal recorded. Echolight specializes in advanced medical imaging technology for bone health assessment, primarily through its flagship product, EchoS, which utilizes proprietary R. E. M.
S. (Radiofrequency Echographic Multi Spectrometry) technology. This innovative device offers a radiation-free alternative for evaluating bone density and quality in the lumbar vertebrae and proximal femur. The EchoS system enables rapid ultrasound scans that produce detailed assessments of bone health within minutes, crucial for early osteoporosis diagnosis, risk stratification, and ongoing monitoring.
Targeted towards healthcare providers, the device serves a diverse patient demographic, including those at risk for osteoporosis, pediatric patients, diabetics, cancer survivors, and pregnant women. EchoS is used in various regions, including Europe, North America, and select markets in Asia and Latin America. In 2023, Echolight generated revenue of EUR 6,567,290. 60 with an EBITDA of EUR 1,881,233.
50. The company generates revenue through direct sales of its EchoS systems to healthcare providers and institutions, typically involving B2B transactions that ensure immediate bone health assessments for patients. Echolight plans to utilize the EUR 4 million raised in Series A funding from CDP Venture Capital and Panakes Partners to expand the adoption of its platform. The company aims to introduce new products and enhance its presence in existing markets while targeting expansion into additional geographic regions.
Specific markets for future growth have yet to be detailed, but the focus will be on increasing accessibility and utilization of the EchoS technology within the healthcare sector.
Current Investors
CDP Venture Capital, Panakes Partners
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Supplies
Website
www.echolight.it
Company Stage
Series A
Total Amount Raised
Subscriber access only
Echolight - timeline of key events
Echolight - financials
| Fiscal Year Ended | Dec 31, 2010 | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 500 | - | - | 1,400 | 41,600 | 86,400 | 183,917 | 792,924 | 1,520,981 | 2,195,913 | 1,111,632 | 2,229,728 | - | - | - |
| % Revenue Growth (YoY) | - | (100.0%) | - | - | 2871.4% | 107.7% | 112.9% | 331.1% | 91.8% | 44.4% | (49.4%) | 100.6% | - | - | - |
| EBITDA (USD) | 1,921 | (166,405) | (217,378) | (188,382) | (164,280) | (224,688) | (661,663) | (636,973) | (577,022) | 105,162 | (744,425) | (945,536) | - | - | - |
| Operating Income (USD) | 1,921 | (166,783) | (218,820) | (191,117) | (167,319) | (439,759) | (880,940) | (882,556) | (843,786) | (171,273) | (813,765) | (1,003,868) | - | - | - |
| Operating Margin | 384.2% | - | - | (13651.2%) | (402.2%) | (509.0%) | (479.0%) | (111.3%) | (55.5%) | (7.8%) | (73.2%) | (45.0%) | - | - | - |
| % EBITDA Margin | 384.2% | - | - | (13455.9%) | (394.9%) | (260.1%) | (359.8%) | (80.3%) | (37.9%) | 4.8% | (67.0%) | (42.4%) | - | - | - |
| NET Income (USD) | 1,394 | (166,775) | (219,366) | (191,207) | (167,334) | (197,378) | (635,999) | (632,430) | (586,192) | (85,884) | (533,256) | (648,493) | - | - | - |
| % Net Margin | 278.8% | - | - | (13657.6%) | (402.2%) | (228.4%) | (345.8%) | (79.8%) | (38.5%) | (3.9%) | (48.0%) | (29.1%) | - | - | - |
Echolight - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.